Podcasts about qlq

Fmarket là sàn giao dịch quỹ mở tập trung được cấp phép, nơi duy nhất giúp Nhà đầu tư dễ dàng lựa chọn và đầu tư vào nhiều quỹ của các Công ty QLQ hàng đầu Việt Nam chỉ với một vài thao tác đơn giản.

You won't wake up one day and suddenly realize that you are your best self and there is no more work to be done. Being your best self doesn't mean that you do not struggle. Once we acknowledge this, it becomes just a little bit easier to recognize that we are so much closer than we think we are. The truth of the matter is, every single day you will wake up and decide which version of you you will be today. In today's episode we are talking all things imposter syndrome, self-sabotage, comparison and feelings of inadequacy.1. You don't have to be your best self all the time in order to get what you want2.Confidence and self-belief are choices that you and everyone else make every single day3. Trusting your path and developing the belief that you are already doing it. It can feel like a constant struggle to be our best selves, but we must acknowledge that your best self is not a destination you will get to, for you are always expanding. And you will always learn more, do more, have more and be more.Have no clue who your best self even is, or struggling with self-belief/self-sabotage? Book your free discovery call hereKeep up with Shar and the QLQ worldinstagram.com/quarter.life.queenswww.quarterlifequeens.com

In today's episode, I'm talking about all things self-sabotage including how and why I almost abandoned my dreams this month. Because in your life quitting will often feel like the easiest option and you will need to be able to overcome that.Topics discussed:Subconscious mind"Negative" thinking and it's purposeRecovering from a negativity spiralHow to reclaim your powerThe secret to accomplishing all of your desiresKeep up with QLQ on Instagram: instagram.com/quarter.life.queensSign Up for Connected: https://quarter-life-queens-academy.teachable.com/p/connected

How much would your life change if you chose to believe in yourself and act as if for a week? What kind of shifts would you see in your mindset, your reality, and what you are able to manifest into your experience? We're exploring all of that and more in today's podcast episode. Your mindset and the small steps you can take every day that will get you where you want to go.Keep up with Shar and the QLQ world:https://linktr.ee/quarter.life.queens

In this week's episode is talking all things intuition, limiting conditioning and manifesting money. Plus we're talking about investments and "bad" decisions.Some of the main points in this podcast episodeThe biggest investment I have ever made in myself at onceYour intuition and why it is quietWhat blocks your intuitive nudgesHow I manifested over 600 dollarsWhy your intuition can't burn youHow to keep up with Shar and the QLQ worldinstagram.com/quarter.life.queenswww.quarterlifequeens.com

On this episode, Shar is talking to you about the biggest transition in her life-leaving her 9-5 Job. I am getting honest with you about what the first 24 hours after leaving my job were like and some of the mixed emotions that came up for me. We are disrupting the idea that you must hate something in order to leaveSome topics that we cover:-outgrowing experiences-gathering the courage to leave-faith in the universe-Managing feelings of lossDoors to QLQ's first-ever course also open this Friday. Stay tuned to the QLQ world for more informationKeep up with Shar:instagram.com/quarter.life.queenswww.quarterlifequeens.com

In this session we will discuss using Splunk to detect a range of Linux-based adversary techniques from MITRE’s ATT&CK™ framework. We will also demonstrate how event sequencing can be used to map a path through the ATT&CK™ matrix and improve overall detection fidelity. We will provide auditd configuration suggestions for Linux endpoints to support greater coverage. Speaker(s) Doug Brown, Senior Information Security Analyst, Red Hat Slides PDF link - https://conf.splunk.com/files/2019/slides/SEC1156.pdf?podcast=1577146233 Product: Splunk Enterprise, Splunk Enterprise Security Track: Security, Compliance and Fraud Level: Advanced

Hello Queen,I am so glad you found your way to the QLQ podcast. The QLQ podcast is a place for spiritual growth and transformation. It is the place for the woman determined to understand herself fully and live the best life she can possibly live. In this episode I'll walk you through who I am, what I can do, where I started and what you can expect from this podcast. Make sure to subscribe so you always know when new content gets posted and you can get my bests tips, resources and strategies for creating the change you crave. And if you loved this episode, please make sure to leave a review or tag us on social media:IG: quarter.life.queensFacebook: Quarter-life queens

On the latest Róisín Meets podcast, singer Cathy Davey tells Róisín Ingle why children need empathy lessons. She talks about returning to music with new album New Forest after six years building the animal rescue she founded with her friends, My Lovely Horse Rescue, and how she got into trouble for writing dirty poems at school. Cathy also plays two songs - Thylacine off the latest album and All of You, from her second album Tales of Silversleeve.

Background: To report our experience with increased dose intensity-modulated radiation and concurrent systemic chemotherapy as definitive treatment of locally advanced esophageal cancer. Patients and methods: We analyzed 27 consecutive patients with histologically proven esophageal cancer, who were treated with increased-dose IMRT as part of their definitive therapy. The majority of patients had T3/4 and/or N1 disease (93%). Squamous cell carcinoma was the dominating histology (81%). IMRT was delivered in step-and-shoot technique in all patients using an integrated boost concept. The boost volume was covered with total doses of 56-60 Gy (single dose 2-2.14 Gy), while regional nodal regions received 50.4 Gy (single dose 1.8 Gy) in 28 fractions. Concurrent systemic therapy was scheduled in all patients and administered in 26 (96%). 17 patients received additional adjuvant systemic therapy. Loco-regional control, progression-free and overall survival as well as acute and late toxicities were retrospectively analyzed. In addition, quality of life was prospectively assessed according to the EORTC QLQs (QLQ-OG25, QLQ-H&N35 and QLQ-C30). Results: Radiotherapy was completed as planned in all but one patient (96%), and 21 patients received more than 80% of the planned concurrent systemic therapy. We observed ten locoregional failures, transferring into actuarial 1-, 2- and 3-year-locoregional control rates of 77%, 65% and 48%. Seven patients developed distant metastases, mainly to the lung (71%). The actuarial 1-, 2- and 3-year-disease free survival rates were 58%, 48% and 36%, and overall survival rates were 82%, 61% and 56%. The concept was well tolerated, both in the clinical objective examination and also according to the subjective answers to the QLQ questionnaire. 14 patients (52%) suffered from at least one acute CTC grade 3/4 toxicity, mostly hematological side effects or dysphagia. Severe late toxicities were reported in 6 patients (22%), mostly esophageal strictures and ulcerations. Severe side effects to skin, lung and heart were rare. Conclusion: IMRT with concurrent systemic therapy in the definitive treatment of esophageal cancer using an integrated boost concept with doses up to 60 Gy is feasible and yields good results with acceptable acute and late overall toxicity and low side effects to skin, lung and heart.

Background: Different approaches for an effective quality management are funded by the Ministry of Health to verify, to assess and, if necessary to optimize the quality of health care using the tracer diagnoses of breast, rectal, and lung cancer in eight regions in Germany. The conception of these observational studies and initial findings are shown here, using breast cancer in the region of Munich (population 2.4 million) as an example. Patients and Methods: The study started on April 1, 1996. The recruitment phase for all primary boast cancer patients in this region is planned for 2 years with a 3-5-year follow-up. Established documentation sheets are used to document basic medical information of each patient, along with the original reports (pathology: radiotherapy, doctors' reports, etc.), follow-up reports and quality of life questionnaires (QLQ, including the EORTC QLQ C30). Results: In 1996, the Munich region has a crude incidence of 125/100,000 women (world standard 71.5). After almost complete documentation the incidence is 10-15% higher. In the period from April 1 1996 to June 30, 1997 1,360 patients have been recruited into the study. 79% of the patients were 50 years of age or older. pT stages are distributed as follows: pTIS 5%, pT1 54%, pT2 32%, pT3 4%, pT4 6%. 4.5% had primary metastases. Breast-conserving therapy (BCT) was performed in 57% of patients. Five of the 46 departments involved recruited more than 50 patients each within these 14 months. These larger departments treat 59% of all patients. The proportion of older patients and pT4 stages is significantly higher in the smaller departments. BCT is performed significantly more often in the larger departments. First results of quality of life show dependencies on age, but no differences between mastectomy and BCT 3 months after operation. Not only the addressed patients (response rate to QLQ over 80%) but also almost all hospitals and many physicians are milling to support and to partake in quality assurance. 35 hospitals, 46 surgical departments. 80 heads of department and surgically: active general practioners, 330 general practioners. 7 radiotherapy departments, and 13 pathology departments have so far documented for this study. Conclusions: An effective quality management in oncology needs a modern cancer registry which uses documentation sheets as well as original reports and organizes the complicated infrastructure for an interdisciplinary cooperation. To be able to evaluate the health care reality it is necessary to carry out a data analysis and assess each individual case. A feedback of the results have to be available for each physician and each department. The cost of this information management is approximately 0.3% of the health care cost for this group of patients.